Category : Seeking Alpha

by Super Admin - 14 hours ago

Elliott Issues Statement on Workday, Inc.

WEST PALM BEACH, Fla., Sept. 16, 2025 /PRNewswire/ -- Elliott Investment Management L.P. ("Elliott"), which manages funds that together hold a significant investment in Workday, Inc. (NASDAQ: WDAY) ("Workday"), today issued the following statement: E...

by Super Admin - 14 hours ago

StubHub Announces Pricing of Initial Public Offering

NEW YORK, Sept. 16, 2025 /PRNewswire/ -- StubHub Holdings, Inc. ("StubHub"), a leading global secondary ticketing marketplace for live events, today announced the pricing of its initial public offering of 34,042,553 shares of its Class A common stock...

by Super Admin - 14 hours ago

Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting

- ASC30 once-daily oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction from baseline after 28-day treatment. - ASC30 tablet's higher efficacy is supported by its higher oral drug exposures. - ASC30 is safe and well tolerat...